The Valley Desk

NCT04703192 · Interventional trial

Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)

Overall registry status Active not recruiting

Phase 2

Conditions Adult T Cell Leukemia/Lymphoma, Relapsed/Refractory Peripheral T-Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov